Benilde Fontoba Poveda

Ms. Benilde Fontoba Poveda

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 September 2024 in Diagnostics
Verified
Journal Article
Open access
PDF file
BMBaget-Bernaldiz Marc
Baget-Bernaldiz Marc
BPBenilde Fontoba Poveda
Benilde Fontoba Poveda
PRPedro ROMERO-AROCA
Pedro ROMERO-AROCA
RNRaul Navarro-Gil
Raul Navarro-Gil
AHAdriana Hernando-Comerma
Adriana Hernando-Comerma
AMAlejandra Mira-Puerto
Alejandra Mira-Puerto
Background: This study aimed to test an artificial intelligence-based reading system (AIRS) capable of reading retinographies of type 2 diabetic (T2DM) patients and a predictive algorithm (DRPA) that predicts the risk of each patient with T2DM of developing diabetic retinopathy (DR). Methods: We tested the ability of the AIRS to read and classify 15,297 retinal photographs from our database of diabetics and 1200 retinal images taken with Messidor-2 into the different DR categories. We tested the DRPA in a sample of 40,129 T2DM patients. The results obtained by the AIRS and the DRPA were then compared with those provided by four retina specialists regarding sensitivity (S), specificity (SP), positive predictive value (PPV), negative predictive value (NPV), accuracy (ACC), and area under the curve (AUC). Results: The results of testing the AIRS for identifying referral DR (RDR) in our database were ACC = 98.6, S = 96.7, SP = 99.8, PPV = 99.0, NPV = 98.0, and AUC = 0.958, and in Messidor-2 were ACC = 96.78%, S = 94.64%, SP = 99.14%, PPV = 90.54%, NPV = 99.53%, and AUC = 0.918. The results of our DRPA when predicting the presence of any type of DR were ACC = 0.97, S = 0.89, SP = 0.98, PPV = 0.79, NPV = 0.98, and AUC = 0.92. Conclusions: The AIRS performed well when reading and classifying the retinographies of T2DM patients with RDR. The DRPA performed well in predicting the absence of DR based on some clinical variables.

18 November 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
PRPedro ROMERO-AROCA
Pedro ROMERO-AROCA
BPBenilde Fontoba Poveda
Benilde Fontoba Poveda
ECEugeni García Curto
Eugeni García Curto
Aida VallsAida Valls
Aida Valls
JCJulián Cristiano
Julián Cristiano
BMBaget-Bernaldiz Marc
Baget-Bernaldiz Marc
Background/Objectives: Telemedicine in diabetic retinopathy (RD) screening is effective but does not reach the entire diabetes population. The use of portable cameras and artificial intelligence (AI) can help in screening diabetes. Methods: We evaluated the ability of two handheld cameras, one based on a smartphone and the other on a smartscope, to obtain images for comparison with OCT. Evaluation was carried out in two stages: the first by two retina specialists and the second using an artificial intelligence algorithm that we developed. Results: The retina specialists reported that the smartphone images required mydriasis in all cases, compared to 73.05% of the smartscope images and 71.11% of the OCT images. Images were ungradable in 27.98% of the retinographs with the smartphone and in 7.98% with the smartscope. The detection of any DR using the AI algorithm showed that the smartphone obtained lower recall values (0.89) and F1 scores (0.89) than the smartscope, with 0.99. Low results were also obtained using the smartphone to detect mild DR (146 retinographs), compared to using the smartscope (218 retinographs). Conclusions: we consider that the use of handheld devices together with AI algorithms for reading retinographs can be useful for DR screening, although the ease of image acquisition through small pupils with these devices needs to be improved.

10 September 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
PRPedro ROMERO-AROCA
Pedro ROMERO-AROCA
BPBenilde Fontoba Poveda
Benilde Fontoba Poveda
ECEugeni García Curto
Eugeni García Curto
AVAida Valls
Aida Valls
JCJulian Cristiano
Julian Cristiano
BMBaget-Bernaldiz Marc
Baget-Bernaldiz Marc
(1) Telemedicine in diabetic retinopathy (RD) screening is effective but does not reach the entire diabetes population. The use of portable cameras and artificial intelligence (AI) can help diabetes screening. (2) Methods: We evaluated the ability of two handheld cameras, one based on a smartphone and the other on a smartscope, to obtain images comparing OCT. Evaluation was done in two stages, the first by two retina specialists and the second using an artificial intelligence algorithm that we developed. (3) Results: The retina specialists report that the smartphone images must mydriasis in all cases compared to 73.05% of the smartscope images and 71.11% of the OCT images. Images were ungradable in 27.98% of the retinographs with the smartphone and 7.98% with the smartscope. The detection of any-DR using the AI algorithm showed that the smartphone obtained lower recall values (0.89) and F1scores (0.89) than the smartscope, with 0.99. The detection of Mild-DR using the smartphone also obtained low results (146 retinographs) compared to the smartscope (218 retinographs). (4) Conclusions: The use of handheld devices together with AI algorithms for reading retinographs can be useful for DR screening, although these devices need to improve the ease image acquisition through small pupils.